Yayın:
CD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using Peripheral Blood Stem Cells. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorMyriam Labopin
dc.contributor.authorDidier Blaise
dc.contributor.authorFabio Ciceri
dc.contributor.authorZafer Gülbaş
dc.contributor.authorÉtienne Daguindau
dc.contributor.authorStéphanie Nguyen‐Quoc
dc.contributor.authorPatrice Chevallier
dc.contributor.authorGèrard Socié
dc.contributor.authorMercedes Colorado
dc.contributor.authorYener Koç
dc.contributor.authorFrancesco Lanza
dc.contributor.authorArnon Nagler
dc.contributor.authorMohamad Mohty
dc.contributor.orcid0000-0001-7356-2328
dc.contributor.orcid0000-0003-4514-4748
dc.contributor.orcid0000-0002-5684-9447
dc.contributor.orcid0000-0003-0873-0123
dc.contributor.orcid0000-0002-4709-0627
dc.contributor.orcid0000-0001-7375-5656
dc.contributor.orcid0000-0003-3142-5581
dc.contributor.orcid0000-0002-2114-7533
dc.contributor.orcid0000-0002-3919-9649
dc.contributor.orcid0000-0002-5189-7167
dc.contributor.orcid0000-0002-0763-1265
dc.date.accessioned2025-11-13T23:01:34Z
dc.date.issued2019-11-13
dc.identifier.doihttps://doi.org/10.1182/blood-2019-123987
dc.identifier.endpage4586
dc.identifier.issn0006-4971
dc.identifier.issueSupplement_1
dc.identifier.openalexW2984763010
dc.identifier.startpage4586
dc.identifier.urihttps://hdl.handle.net/11421/16087
dc.identifier.urihttps://doi.org/10.1182/blood-2019-123987
dc.identifier.volume134
dc.language.isoen
dc.relation.ispartofBlood
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectHematopoietic stem cell transplantation
dc.subjectTransplantation
dc.subjectMyeloid leukemia
dc.subjectInternal medicine
dc.subjectCD34
dc.subjectCyclophosphamide
dc.subjectLeukemia
dc.subjectStem cell
dc.subjectGastroenterology
dc.subjectGraft-versus-host disease
dc.subjectMyeloid
dc.subjectImmunology
dc.subjectOncology
dc.subjectChemotherapy
dc.subjectBiology
dc.titleCD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using Peripheral Blood Stem Cells. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5058571002

Dosyalar

Koleksiyonlar

Publications